Evoke Pharma Ratios (2020-2025) | EVOK

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 28.39%71.16%93.72%62.09%94.56%85.32%89.21%76.13%93.76%94.93%97.77%96.48%94.67%98.37%96.08%96.42%98.65%95.53%97.62%
EBT Margin 239,100.72%4,213.71%3,808.20%-2,997.78%-968.01%-211.67%-463.81%-519.54%-483.63%-242.02%-226.43%-276.78%-165.10%-108.39%-118.58%-91.03%-49.67%-49.45%-36.05%-42.41%-41.87%-26.99%
EBIT Margin 239,017.36%4,115.76%3,709.51%-2,864.88%-916.60%-198.27%-429.14%-490.27%-457.48%-229.85%-214.70%-265.93%-157.72%-102.60%-112.64%-86.50%-47.96%-48.44%-36.08%-42.26%-41.55%-26.56%
EBITDA Margin 239,017.36%4,115.76%3,709.51%-2,864.88%-916.60%-198.27%-429.14%-490.27%-457.48%-229.85%-214.70%-265.93%-157.72%-102.60%-112.64%-86.50%-47.96%-48.44%-36.08%-42.26%-41.55%-26.56%
Operating Margin 239,017.36%4,115.76%3,709.51%-2,864.88%-916.60%-198.27%-429.14%-490.27%-457.48%-229.85%-214.70%-265.93%-157.72%-102.60%-112.64%-86.50%-47.96%-48.44%-36.08%-42.26%-41.55%-26.56%
Net Margin 239,100.72%4,213.71%3,808.20%-2,997.78%-968.01%-211.67%-463.81%-519.54%-483.63%-242.02%-226.43%-276.78%-165.10%-108.39%-118.58%-91.03%-49.67%-49.45%-36.05%-42.41%-41.87%-26.99%
FCF Margin 53,400.14%3,583.22%2,873.97%-3,265.97%-638.32%-633.26%-553.90%-386.02%-297.47%-132.31%-314.72%-201.24%-106.63%-66.65%-66.00%-148.63%-32.16%-30.85%-37.48%-32.38%-15.06%-12.18%
Efficiency
Inventory Average 0.16M0.24M0.24M0.23M0.21M0.23M0.27M0.24M0.25M0.33M0.44M0.51M0.49M0.54M0.57M0.52M0.47M0.49M0.59M0.62M
Assets Average 6.45M7.51M8.09M14.36M18.43M14.60M11.11M9.80M11.72M13.91M12.63M10.95M9.51M8.42M7.46M9.76M12.30M13.14M15.84M16.95M16.22M15.85M
Equity Average 1.27M-1.15M-2.57M2.30M6.89M5.37M4.16M2.74M4.56M6.36M4.81M3.11M1.33M-0.17M-1.73M0.46M3.08M3.53M5.71M6.44M5.11M3.87M
Invested Capital 2.92M-0.37M-1.92M-3.21M7.81M5.97M4.77M3.56M1.93M7.19M5.53M4.08M2.13M0.54M-0.87M-2.58M3.50M2.66M4.39M7.04M5.84M4.37M3.36M
Asset Utilization Ratio -0.010.000.010.080.150.200.190.150.200.270.380.510.690.630.610.660.650.680.790.91
Leverage & Solvency
Interest Coverage Ratio -0.00M-41.16-37.10-21.00-17.40-14.64-12.28-16.64-16.95-15.18-13.57-17.48-14.31-12.72-14.98-12.04-9.82-10.20-9.47-10.56-12.51-9.03
Debt to Equity -5.35-1.04-1.560.640.841.051.412.590.700.901.222.35-9.295.72-1.94
Debt Ratio 0.240.300.530.260.280.430.470.550.350.370.420.50-0.56-0.640.71
Equity Ratio 0.63-0.05-0.28-0.340.400.340.410.340.210.500.410.340.210.06-0.11-0.360.280.220.310.400.360.270.21
Times Interest Earned -0.00M-41.16-37.10-21.00-17.40-14.64-12.28-16.64-16.95-15.18-13.57-17.48-14.31-12.72-14.98-12.04-9.82-10.20-9.47-10.56-12.51-9.03
Valuation
Enterprise Value -4.13M-7.99M-6.28M-8.07M-18.19M-16.72M-11.14M-9.14M-7.70M-13.50M-12.40M-9.84M-8.21M-7.01M-5.96M-4.74M-9.70M-9.20M-11.34M-13.60M-12.62M-12.10M-11.60M
Return Ratios
Return on Sales 2,391.01%42.14%38.08%-29.98%-9.68%-2.12%-4.64%-5.20%-4.84%-2.42%-2.26%-2.77%-1.65%-1.08%-1.19%-0.91%-0.50%-0.49%-0.36%-0.42%-0.42%-0.27%
Return on Capital Employed -1.71%-0.74%-0.67%-0.84%-0.90%-0.73%-0.63%-0.71%-0.85%-7.08%23.36%3.40%-8.42%-2.20%-1.75%-0.95%-0.77%-1.16%-1.44%
Return on Assets -1.40%-0.98%-0.51%-0.63%-0.78%-0.83%-0.69%-0.58%-0.65%-0.76%-0.83%-0.90%-1.04%-0.73%-0.53%-0.47%-0.34%-0.30%-0.33%-0.33%
Return on Equity 4.42%-6.12%-1.36%-1.72%-2.08%-2.95%-1.76%-1.27%-1.71%-2.67%-5.95%45.37%4.51%-15.54%-2.12%-1.74%-0.94%-0.79%-1.05%-1.35%